HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status

Background. Although specific human immunodeficiency virus type 1 (HIV-1) drug resistance mutations are well studied, little is known about cumulative amino acid changes, or how regimen and participant characteristics influence these changes. Methods. In the AIDS Clinical Trials Group randomized stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mollan, Katie, Daar, Eric S., Sax, Paul E., Balamane, Maya, Collier, Ann C., Fischl, Margaret A., Lalama, Christina M., Bosch, Ronald J., Tierney, Camlin, Katzenstein, David
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2012
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3502379/
https://ncbi.nlm.nih.gov/pubmed/23148287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis613
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares